Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 200

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Carvedilol

Frishman, William H. · 1998 · New England Journal of Medicine

Abstract

Carvedilol is a β-adrenoreceptor–antagonist drug with α1-adrenoreceptor–antagonist activity. It was approved in the United States in September 1995 for the treatment of patients with essential hypertension and in May 1997, on the basis of the results of several clinical trials,18 became the first adrenoreceptor-blocking drug to receive approval for the treatment of symptomatic heart failure.Pharmacodynamic and Pharmacokinetic PropertiesCarvedilol is a racemic lipophilic aryloxypropanolamine (Figure 1) that causes both precapillary vasodilatation by means of α1-adrenoreceptor blockade and nonselective β-adrenoreceptor blockade and is devoid of intrinsic sympathomimetic activity.9 Its membrane-stabilizing activity is less than that . . .

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejm199812103392407

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 200

Metadata

Authors
Frishman, W. H.
Venue
New England Journal of Medicine
Published
1998-12-10
Volume
339
Issue
24
Pages
1759-1765
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4205320581
Cited by
200
References
3
FWCI
9.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Carvedilol. https://app.cochat.ai/papers/10.1056/nejm199812103392407
The paper
Frishman, W. H. (1998). Carvedilol. New England Journal of Medicine. https://doi.org/10.1056/nejm199812103392407

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.